MED financial statements and SEC filings
MED annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $385.79M | -$14.21M | -$18.67M | 10-K |
| 2024-12-31 | $602.46M | $2.88M | $2.09M | 10-K |
| 2023-12-31 | $1.07B | $126.40M | $99.42M | 10-K |
| 2022-12-31 | $1.60B | $184.81M | $143.57M | 10-K |
| 2021-12-31 | $1.53B | $216.24M | $164.03M | 10-K |
| 2020-12-31 | $934.84M | $134.16M | $102.86M | 10-K |
MED annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $247.97M | $49.05M | $198.92M | 10-Q |
| 2024-12-31 | $284.21M | $74.10M | $210.11M | 10-K |
| 2023-12-31 | $309.91M | $108.43M | $201.48M | 10-K |
| 2022-12-31 | $316.21M | $161.17M | $155.04M | 10-K |
| 2021-12-31 | $398.33M | $195.85M | $202.47M | 10-K |
| 2020-12-31 | $276.08M | $118.84M | $157.25M | 10-K |
MED annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $6.86M | -$5.61M | -$564.00K | 10-K |
| 2024-12-31 | $24.48M | -$7.45M | -$1.51M | 10-K |
| 2023-12-31 | $147.66M | -$6.48M | -$79.79M | 10-K |
| 2022-12-31 | $194.57M | -$16.68M | -$199.58M | 10-K |
| 2021-12-31 | $94.55M | -$34.21M | -$125.13M | 10-K |
| 2020-12-31 | $145.20M | -$5.89M | -$57.14M | 10-K |